These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10624478)

  • 21. Neuropsychiatric features in 36 pathologically confirmed cases of corticobasal degeneration.
    Geda YE; Boeve BF; Negash S; Graff-Radford NR; Knopman DS; Parisi JE; Dickson DW; Petersen RC
    J Neuropsychiatry Clin Neurosci; 2007; 19(1):77-80. PubMed ID: 17308231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid eye movement (REM) sleep without atonia in two patients with corticobasal degeneration (CBD).
    Gatto EM; Uribe Roca MC; Martínez O; Valiensi S; Högl B
    Parkinsonism Relat Disord; 2007 Mar; 13(2):130-2. PubMed ID: 17055327
    [No Abstract]   [Full Text] [Related]  

  • 23. [A case of corticobasal degeneration presenting with visual hallucination].
    Nagaoka K; Ookawa S; Maeda K
    Rinsho Shinkeigaku; 2004 Mar; 44(3):193-7. PubMed ID: 15233273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Corticobasal degeneration.
    Stover NP; Watts RL
    Semin Neurol; 2001; 21(1):49-58. PubMed ID: 11346025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. White matter changes in corticobasal degeneration syndrome and correlation with limb apraxia.
    Borroni B; Garibotto V; Agosti C; Brambati SM; Bellelli G; Gasparotti R; Padovani A; Perani D
    Arch Neurol; 2008 Jun; 65(6):796-801. PubMed ID: 18541800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extrapyramidal symptoms in Wilson's disease are associated with olfactory dysfunction.
    Mueller A; Reuner U; Landis B; Kitzler H; Reichmann H; Hummel T
    Mov Disord; 2006 Sep; 21(9):1311-6. PubMed ID: 16763975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Corticobasal degeneration and atypical progressive supranuclear palsy: their symptomatology, laboratory examination and differential diagnosis].
    Morimatsu M; Negoro K; Mori H
    Rinsho Shinkeigaku; 2004 Nov; 44(11):982-5. PubMed ID: 15651349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mixing pro- and antisaccades in patients with parkinsonian syndromes.
    Rivaud-Péchoux S; Vidailhet M; Brandel JP; Gaymard B
    Brain; 2007 Jan; 130(Pt 1):256-64. PubMed ID: 17124191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Putaminal signal hypointensity on T2 weighted MR image in a patient with corticobasal degeneration].
    Tsunoda M; Yukino T; Koike H; Yoshino Y; Kamiyama M
    Rinsho Shinkeigaku; 2000 Jan; 40(1):59-61. PubMed ID: 10825804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eye movement disorders in corticobasal degeneration.
    Vidailhet M; Rivaud-Péchoux S
    Adv Neurol; 2000; 82():161-7. PubMed ID: 10624480
    [No Abstract]   [Full Text] [Related]  

  • 31. Dystonia in corticobasal degeneration.
    Vanek ZF; Jankovic J
    Adv Neurol; 2000; 82():61-7. PubMed ID: 10624471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parkinsonism in corticobasal degeneration.
    Lang AE
    Adv Neurol; 2000; 82():83-9. PubMed ID: 10624473
    [No Abstract]   [Full Text] [Related]  

  • 33. Corticobasal degeneration: clinical aspects.
    Bak TH; Hodges JR
    Handb Clin Neurol; 2008; 89():509-21. PubMed ID: 18631773
    [No Abstract]   [Full Text] [Related]  

  • 34. Current and future management of the corticobasal syndrome and corticobasal degeneration.
    Boeve BF; Josephs KA; Drubach DA
    Handb Clin Neurol; 2008; 89():533-48. PubMed ID: 18631775
    [No Abstract]   [Full Text] [Related]  

  • 35. [Intracranial inhibitory mechanisms in clinically diagnosed corticobasal degeneration: a study of a silent period followed by transcranial magnetic stimulation].
    Fujimoto K; Sayama S; Shizuma N; Kano M; Nakano I
    Rinsho Shinkeigaku; 2000 Jul; 40(7):701-6. PubMed ID: 11186908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel approaches to studying basal ganglia and related neuropsychiatric disorders. Preface.
    Lu XH
    Int Rev Neurobiol; 2009; 89():xi. PubMed ID: 19900612
    [No Abstract]   [Full Text] [Related]  

  • 37. Quantifier comprehension in corticobasal degeneration.
    McMillan CT; Clark R; Moore P; Grossman M
    Brain Cogn; 2006 Dec; 62(3):250-60. PubMed ID: 16949714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distribution of astrocytic plaques in the corticobasal degeneration brain and comparison with tuft-shaped astrocytes in the progressive supranuclear palsy brain.
    Hattori M; Hashizume Y; Yoshida M; Iwasaki Y; Hishikawa N; Ueda R; Ojika K
    Acta Neuropathol; 2003 Aug; 106(2):143-9. PubMed ID: 12732936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysarthria and orofacial apraxia in corticobasal degeneration.
    Ozsancak C; Auzou P; Hannequin D
    Mov Disord; 2000 Sep; 15(5):905-10. PubMed ID: 11009198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A 65-year-old man with rigid-bradykinetic parkinsonism, vertical gaze palsy, difficulty of eye-lid opening, and marked pseudo-bulbar palsy].
    Noda K; Kobayashi T; Matsuoka S; Takanashi M; Kanazawa A; Mizuno Y
    No To Shinkei; 2005 Jan; 57(1):73-86. PubMed ID: 15782604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.